Aethlon Medical (AEMD) Misses Q3 EPS by 7c

Aethlon Medical (NASDAQ: AEMD) reported Q3 EPS of ($1.37), $0.07 worse than the analyst estimate of ($1.30).

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Four High-Impact Small Caps Enter the Spotlight
• H.C. Wainwright Reiterates Neutral Rating on Aethlon Medical (AEMD)